Company Profiles

driven by the PitchBook Platform

Trellis Bioscience

Description

Provider of human antibodies for treating infectious disease. The company engages in the discovery of therapeutic monoclonal antibodies for the treatment of cancer.

1998

Founded

PRIVATE

Status

11-50

Employees

Grant

Latest Deal Type

$3.3M

Latest Deal Amount

$48.2M

Total Amount Raised

Description

Provider of human antibodies for treating infectious disease. The company engages in the discovery of therapeutic monoclonal antibodies for the treatment of cancer.

Website:

www.trellisbio.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery
Pharmaceuticals

Primary Office

1505-B O'Brien Drive Menlo Park, CA 94025United States +1 (650) 838-1400
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Trellis Bioscience's full profile, request a free trial.

Trellis Bioscience Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Trellis Bioscience Investors (9)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Easton Capital Investment GroupVenture CapitalMinority000 0000000 0000
Forward VenturesVenture CapitalMinority000 0000000 0000
InvestBio VenturesVenture CapitalMinority000 0000000 0000
MorgenthalerVenture CapitalMinority000 0000000 0000
National Institute Of Allergy and Infectious Diseases Extramural ActivitesGovernment000 0000000 0000
Easton Capital Investment Group Venture Capital
Forward Ventures Venture Capital
InvestBio Ventures Venture Capital
Morgenthaler Venture Capital
National Institute Of Allergy and Infectious Diseases Extramural Activites Government

Trellis Bioscience Executive Team (10)

NameTitleBoard
Seat
Contact
Info
Stefan Ryser Ph.DPresident, Board Member & Chief Executive Officer
Stote EllsworthCo-Chief Technology Officer & Board Member
Bruce Keyt Ph.DCo-Chief Technology Officer & Chief Scientific Officer
Reyna Simon Ph.DDirector, Project and Alliance Management
Bill UsingerHead, Research & Development & Vice President
Stefan Ryser Ph.D President, Board Member & Chief Executive Officer
Stote Ellsworth Co-Chief Technology Officer & Board Member
Bruce Keyt Ph.D Co-Chief Technology Officer & Chief Scientific Officer
Reyna Simon Ph.D Director, Project and Alliance Management
Bill Usinger Head, Research & Development & Vice President

Trellis Bioscience Board Members (7)

NameRepresentingRoleSinceContact
Info
Jack AnthonySelfBoard Member000 0000
John Friedman JDEaston Capital Investment GroupFounding Partner & Managing Partner000 0000
John Saxe JDSelfChairman000 0000
Markus Goebel Ph.DNovartis Venture FundsManaging Director000 0000
Shirley ClaytonSelfBoard Member000 0000
Jack Anthony Board Member Self
John Friedman JD Founding Partner & Managing Partner Easton Capital Investment Group
John Saxe JD Chairman Self
Markus Goebel Ph.D Managing Director Novartis Venture Funds
Shirley Clayton Board Member Self
Request full access to PitchBook